Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1981 2
1984 2
1985 3
1987 6
1988 7
1989 9
1990 10
1991 14
1992 13
1993 17
1994 15
1995 17
1996 10
1997 6
1998 12
1999 14
2000 7
2001 13
2002 7
2003 4
2004 5
2005 6
2006 8
2007 8
2008 1
2009 2
2010 9
2011 8
2012 4
2013 7
2014 7
2015 6
2016 4
2017 6
2018 7
2019 8
2020 5
2021 8
2022 3
2023 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Results by year

Filters applied: . Clear all
Page 1
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Spunt SL, Million L, Chi YY, Anderson J, Tian J, Hibbitts E, Coffin C, McCarville MB, Randall RL, Parham DM, Black JO, Kao SC, Hayes-Jordan A, Wolden S, Laurie F, Speights R, Kawashima E, Skapek SX, Meyer W, Pappo AS, Hawkins DS. Spunt SL, et al. Among authors: parham dm. Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2. Epub 2019 Nov 27. Lancet Oncol. 2020. PMID: 31786124 Free PMC article.
Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jordan AA, Paidas CN, Parham DM, Teot LA, Wharam MD, Breneman JC, Donaldson SS, Anderson JR, Meyer WH. Arndt CA, et al. Among authors: parham dm. J Clin Oncol. 2009 Nov 1;27(31):5182-8. doi: 10.1200/JCO.2009.22.3768. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770373 Free PMC article. Clinical Trial.
Extrarenal Wilms' tumor.
Fernandes ET, Kumar M, Douglass EC, Wilimas J, Parham DM, Rao BN. Fernandes ET, et al. Among authors: parham dm. J Pediatr Surg. 1989 May;24(5):483-5. doi: 10.1016/s0022-3468(89)80407-5. J Pediatr Surg. 1989. PMID: 2544714 Review.
Anti-CD45.
Parham DM. Parham DM. Am J Surg Pathol. 1995 Jun;19(6):732-4. doi: 10.1097/00000478-199506000-00018. Am J Surg Pathol. 1995. PMID: 7755161 No abstract available.
Pediatric Sarcomas: The Next Generation of Molecular Studies.
Giannikopoulos P, Parham DM. Giannikopoulos P, et al. Among authors: parham dm. Cancers (Basel). 2022 May 20;14(10):2515. doi: 10.3390/cancers14102515. Cancers (Basel). 2022. PMID: 35626119 Free PMC article. Review.
Soft tissue sarcomas in children.
Pappo AS, Parham DM, Rao BN, Lobe TE. Pappo AS, et al. Among authors: parham dm. Semin Surg Oncol. 1999 Mar;16(2):121-43. doi: 10.1002/(sici)1098-2388(199903)16:2<121::aid-ssu5>3.0.co;2-#. Semin Surg Oncol. 1999. PMID: 9988868 Review.
291 results